http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f62678e48223597c011a419f11b7dd4d
Outgoing Links
Predicate | Object |
---|---|
family-name | Koob F. Koob |
name | George F Koob George F. Koob |
given-name | George F George George F. |
organization-name | Department of Neuropharmacology, Scripps Research Institute, La Jolla, CA 92037. Committee on the Neurobiology of Addictive Disorders, The Scripps Research Institute10550 North Torrey Pines Road, SP30-2400, La Jolla, CA 92037, USA National Institute on Alcohol Abuse and Alcoholism (NIH) Rockville Maryland USA Committee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, La Jolla, CA, USA. Electronic address: gkoob@scripps.edu. National Institute on Alcohol Abuse and Alcoholism, Bethesda, Md. (all authors); National Institute on Drug Abuse, Bethesda, Md. (Koob). National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland, USA; The Scripps Research Institute, Department of Neuropharmacology (A.C., F.D., G.F.K., L.H.G.), La Jolla, California 92037 National Institute on Drug Abuse, National Institutes of Health Bethesda MD USA National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Rockville, MD, USA Integrative Neuroscience Research Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, USA. george.koob@nih.gov. Neurobiology of Addiction Section, Intramural Research Program National Institute on Drug Abuse, National Institutes of Health Baltimore Maryland USA National Institutes of Health, Bethesda, MD, United States National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Rockville, MD, USA. george.koob@nih.gov. National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA. george.koob@nih.gov. Department of Neuropharmacology, The Scripps Research Institute, La Jolla, California NIH/NIAAA Bethesda Maryland Neurobiology of Addiction Section National Institute on Drug Abuse Intramural Research Program National Institutes of Health Baltimore Maryland Departments of Chemistry, Immunology, and Neuropharmacology, and The Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037 Division of Preclinical Neuroscience and Endocrinology, Scripps Clinic and Research Foundation, La Jolla, CA 92037 National Institute on Drug Abuse Baltimore Maryland USA Arthur Vining Davis Center for Behavioral Neurobiology, Salk Institute, San Diego, California 92138 Neurobiology of Addiction Section, Integrative Neuroscience Research Branch National Institute on Drug Abuse Baltimore Maryland USA; National Institute on Alcohol Abuse and Alcoholism National Institutes of Health Bethesda Maryland USA Department of Neuropharmacology, The Scripps Research Institute, La Jolla, CA 92103; Laboratoire de Neuropsychobiologie des Desadaptations, Université Victor Segalen Bordeaux 2, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5541, 33076 Bordeaux, France; Dipartmento di Scienze della Salute, Instituto Universitario di Scienze Motorie, Piazza Lauro De Bosis 15, 00194 Rome, Italy; and Behavioral Neuroscience Branch, Intramural Research Program, National Institute on Drug Abuse,... Departments of Neuropharmacology and Chemistry and Molecular Biology, The Scripps Research Institute, La Jolla, CA 92037 Division of Psychopharmacology, Department of Neuropharmacology, The Scripps Research Institute, 92037, La Jolla, CA Integrative Neuroscience Research Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, USA. Division of Psychopharmacology, Department of Neuropharmacology, The Scripps Research Institute, La Jolla, California Committee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, La Jolla, CA 92037 Center for Psychiatric Neuroscience and Service Universitaire de Psychiatrie de l'Enfant et de l'Adolescent (SUPEA), Centre Hospitalier Universitaire Vaudois-Département de Psychiatrie (CHUV-DP), University of Lausanne, CH-1008 Prilly, Switzerland; and Departments of Molecular Biology and Molecular and Integrative Neurosciences, The Scripps Research Institute, La Jolla, CA 92037 Committee on the Neurobiology of Addictive Disorders The Scripps Research Institute La Jolla CA USA; Skaggs School of Pharmacy and Pharmaceutical Sciences University of California San Diego La Jolla CA USA Departments of Chemistry, Immunology, and Molecular Biology, Molecular and Integrated Neurosciences Department, The Skaggs Institute for Chemical Biology, and Worm Institute for Research and Medicine, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037 Division of Psychopharmacology, Department of Neuropharmacology, The Scripps Research Institute, La Jolla, CA, USA Departments of Chemistry and Molecular Biology and Neuropharmacology, The Scripps Research Institute and the Skaggs Institute for Chemical Biology, 10550 North Torrey Pines Road, La Jolla, CA 92037 The Scripps Research Institute; La Jolla CA USA National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Rockville, Maryland Molecular and Integrative Neurosciences Department, The Scripps Research Institute, La Jolla, California, USA. Department of Neuropharmacology, The Scripps Research Institute, La Jolla, USA M. Spina, E. Merlo-Pich, A. M. Basso, G. F. Koob, Department of Neuropharmacology, The Scripps Research Institute, 10666 North Torrey Pines Road, La Jolla, CA 92037, USA. Contribution from the Departments of Chemistry and Immunology, The Skaggs Institute for Chemical Biology, Worm Institute for Research and Medicine, and the Committee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037 The Scripps Research Institute, La Jolla, CA 92037 Division of Preclinical Neuroscience and Endocrinology, Scripps Clinic and Research Foundation A. V. Davis Center for Behavioral Neurobiology, The Salk Institute, San Diego, California 92138 Office of the Clinical Director, National Institute on Alcohol Abuse and Alcoholism (NIAAA), Bethesda (Kwako, Schwandt, Diazgranados, Goldman); Section on Human Psychopharmacology, NIAAA, Bethesda (Ramchandani); Office of the Director, NIAAA, Bethesda (Koob); Office of the Director, NIDA, Bethesda (Volkow); Division of Epidemiology, Services, and Prevention, NIDA, Bethesda (Blanco); and Laboratory of Neurogenetics, NIAAA, Bethesda (Goldman). National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland Committee on Neurobiology of Addictive Disorders, The Scripps Research Institute, La Jolla, California 92037, United States National Institute of Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, United States Department of Neuropharmacology The Scripps Research Institute, La Jolla, CA The Scripps Research Institute La Jolla California The Scripps Research Institute, Committee on the Neurobiology of Addictive Disorders, 10550 North Torrey Pines Road, SP30-2400, La Jolla, CA 92037, USA. gkoob@scripps.edu Office of the Director; National Institute on Alcohol Abuse and Alcoholism; Bethesda Maryland Departments of Chemistry and Immunology, the Skaggs Institute for Chemical Biology, the Worm Institute of Research and Medicine, and Committee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037 Psychological Laboratory, University of Cambridge, Cambridge CB2 3EB, England National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA Committee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, 10550 North Torrey Pines Road, SP30-2400, La Jolla, CA 92037, USA. gkoob@scripps.edu Department of Neuropharmacology, Scripps Research Institute, La Jolla, California 92037, USA. Committee on the Neurobiology of Addictive Disorders, and Department of Neuropharmacology, The Scripps Research Institute, La Jolla, CA 92037 F. Rodrı́guez de Fonseca and M. Navarro, Instituto Complutense de Drogodependencias, Departamento de Psicobiologı́a, Facultad de Psicologı́a, Universidad Complutense de Madrid, 28223 Madrid, Spain.; M. R. A. Carrera, G. F. Koob, F. Weiss, Department of Neuropharmacology, Scripps Research Institute, La Jolla, CA 92037, USA. National Institute on Alcohol Abuse and Alcoholism, Rockville, Maryland, USA *Committee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, La Jolla, CA 92037; and Committee on the Neurobiology of Addictive DisordersThe Scripps Research InstituteLa Jolla CaliforniaUSA Committee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, La Jolla, CA 92037, USA. National Institute on Drug Abuse, Bethesda, MD 21224, USA National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD 20892, USA.; National Institute on Drug Abuse, Baltimore, MD 21224, USA. Department of Neuropharmacology, From the Scripps Research Institute, La Jolla, California G. F. Koob is at The Scripps Research Institute, Department of Neuropharmacology CVN-7, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.; M. Le Moal is at the University of Bordeaux II, INSERM, Unite 259, rue Camille Saint-Saens, Bordeaux, Cedex 33077, France. Departments of Chemistry and Neuropharmacology, The Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037 National Institute on Alcohol Abuse and Alcoholism and Intramural Research Program, National Institute on Drug, National Institutes of Health, Bethesda, MD Committee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, La Jolla, CA 92037. Committee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, La Jolla, California 92037;, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, USA National Institute on Alcohol Abuse and Alcoholism NIH Bethesda Maryland; National Institute on Drug Abuse National Institutes of Health, NIH Baltimore Maryland Department of Neuropharmacology, The Scripps Research Institute, La Jolla, CA 92037. From the Division of Psychopharmacology, Department of Neuropharmacology, The Scripps Research Institute, La Jolla, California Committee on the Neurobiology of Addictive Disorders The Scripps Research Institute La Jolla CA USA Committee on the Neurobiology of Addictive Disorders,; Pearson Center for Alcoholism and Addiction Research, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Md. Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California, San Diego, San Diego, California. Associate Member, Scripps Clinic and Research Foundation. Research Institute of Scripps Clinic, La Jolla, CA 92037. Committee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, La Jolla, CA, USA. National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224 Director, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland Department of Neuropharmacology, The Scripps Research Institute, La Jolla, CA, USA Psychological Laboratory, University of Cambridge, Cambridge, CB2 3EB, England Committee on the Neurobiology of Addictive Disorders, The Scripps Research Institute La Jolla California Department of Neuropharmacology, The Scripps Research Institute, La Jolla, CA 92037, USA Committee on the Neurobiology of Addictive Disorders and National Institute on Alcohol Abuse and Alcoholism, NIH, Bethesda, MD 20892, USA. Committee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, United States Committee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, La Jolla, CA, USA Department of Neuropharmacology CVN-7, The Scripps Research Institute, La Jolla, CA, USA Committee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, La Jolla, California 92037; |
Incoming Links
Total number of triples: 723.